Bluejay Diagnostics, Inc. (BJDX)
2025-06-30 | ||||
|---|---|---|---|---|
| Sales and marketing | - | |||
| Research and development | 889,896 | |||
| General and administrative | 1,095,465 | |||
| Total operating expenses | 1,985,361 | |||
| Operating loss | -1,985,361 | |||
| Other income, net | -275 | |||
| Interest income | 29,254 | |||
| Interest expense | 222 | |||
| Total other income (expense), net | 28,757 | |||
| Net loss | -1,956,604 | |||
| Net loss per share - basic (in dollars per share) | -1.41 | |||
| Net loss per share -diluted (in dollars per share) | -1.41 | |||
| Weighted average common shares outstanding basic (in shares) | 1,387,118 | |||
| Weighted average common shares outstanding diluted (in shares) | 1,387,118 | |||